GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer
Abstract Background: Basal-like breast cancer (BLBC) takes up about 10–20% of all breast cancer(BC), what’s more, BLBC has the lowest…
Abstract Background: Basal-like breast cancer (BLBC) takes up about 10–20% of all breast cancer(BC), what’s more, BLBC has the lowest…
Abstract Recently, increasing numbers of studies have demonstrated that transient receptor potential ankyrin 1 (TRPA1) can be used as a…